In vivo HPV 16 E5 mRNA: Expression pattern in patients with squamous intra-epithelial lesions of the cervix

Journal of Clinical Virology

Volumn 52, Issue 2, 2011, Pages 79-83

  Lorenzon, Laura ^a   Mazzetta, Francesca ^a   Venuti, Aldo ^b   Frega, Antonio ^c   Torrisi, Maria Rosaria ^a   French, Deborah ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

E5; HPV 16; HSIL; LSIL

Indexed keywords

MESSENGER RNA;

ADULT; ARTICLE; CELL LINE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOLOGY; DISEASE COURSE; FEMALE; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; IN VIVO STUDY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS EPITHELIUM; UTERINE CERVIX DISEASE; UTERINE CERVIX EPITHELIUM; VIRUS TRANSCRIPTION;

ADOLESCENT; ADULT; CELL LINE, TRANSFORMED; CERVIX UTERI; FEMALE; GENE EXPRESSION REGULATION, VIRAL; HUMAN PAPILLOMAVIRUS 16; HUMANS; MIDDLE AGED; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS INFECTIONS; PRECANCEROUS CONDITIONS; RNA, MESSENGER; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 80052703402     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2011.06.007     Document Type: Article

References (34)

1. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines™). Cervical Cancer. Version 1.2011. http://www.nccn.org/.
2. Parkin D.M., Bray F., Ferlay J., Pisani P. Global cancer statistics 2002. CA Cancer J Clin 2005, 55:74-7108.
3. Kamangar F., Dores G.M., Anderson W.K. Patterns of cancer incidence, mortality and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 2006, 24:2137-2150.
4. Zhi-Ming Z., Backer C.C. Papillomavirus genome structure, expression, and post-transcriptional regulation. Front Biosci 2006, 11:2286-2302.
5. Tonon S.A., Piccioni M.A., Bos P.D., Zinovich J.B., Galuppo J., Alonio L.V., et al. Physical status of the E2 human papilloma virus 16 viral gene in cervical preneoplastic and neoplastic lesions. J Clin Virol 2001, 21:129-134.
6. Nagao S., Yoshinouchi M., Miyagi Y., Hongo A., Kodama J., Itoh S., et al. Rapid and sensitive detection of physical status of Human Papillomavirus type 16 DNA by quantitative real-time PCR. J Clin Microbiol 2002, 40:863-867.
7. Hafner N., Driesch C., Gajda M., Jansen L., Kirchmayr R., Runnebaum I.B., et al. Integration of the HPV16 genome does not invariably result in high levels of viral oncogene transcripts. Oncogene 2008, 27:1610-1617.
8. Oetke C., Auvinen E., Pawlita M., Alonso A. Human Papillomavirus type 16 E5 protein localizes to the Golgi apparatus but does not grossly affect cellular glycosylation. Arch Virol 2000, 145:2183-2191.
9. Leechanachai P., Banks L., Moreau F., Matlashewski G. The E5 gene from human papillomavirus type 16 is an oncogene which enhances growth factor-mediated signal transduction to the nucleus. Oncogene 1992, 7:19-25.
10. Pim D., Collins M., Banks L. Human papillomavirus type 16 E5 gene stimulates the transforming activity of the epidermal growth factor receptor. Oncogene 1992, 7:27-32.
11. Bouvard V., Matlashewski G., Gu Z.-M., Storey A., Banks L. The human papillomavirus type 16 E5 gene cooperates with the E7 gene to stimulate proliferation of primary cells and increases viral gene expression. Virology 1994, 203:73-80.
12. Valle G., Banks L. The human papillomavirus (HPV)-6 and HPV-16 E5 proteins co-operate with HPV-16 E7 in the transformation of primary rodent cells. J Gen Virol 1995, 76:1239-1245.
13. Straight S.W., Hinkle P.M., Jewers R.J., McCance D.J. The E5 oncoprotein of human papillomavirus type 16 transforms fibroblasts and effects the downregulation of the epidermal growth factor receptor in keratinocytes. J Virol 1993, 67:4521-4532.
14. Venuti A., Salani D., Poggiali F., Manni, Bagnato A. The E5 oncoprotein of human papillomavirus type 16 enhances endothelin-1-induced keratinocyte growth. Virology 1998, 248:1-5.
15. DiMaio D., Mattoon D. Mechanisms of cell transformation by papillomavirus E5 proteins. Oncogene 2001, 20:7866-7873.
16. Maufort J.P., Shai A., Pitot H.C., Lambert P.F.A. A role for HPV 16 E5 in cervical carcinogenesis. Cancer Res 2010, 70:2924-2931.
17. Asrafi G.H., Haghshenas M., Marchetti B., Campo M.S. E5 protein of human papillomavirus 16 downregulates HLA class I and interacts with the heavy chain via its first hydrophobic domain. Int J Cancer 2006, 119:2105-2112.
18. Gruener M., Bravo I.G., Momburg F., Alonso A., Tomakidi P. The E5 protein of the human papillomavirus type 16 down-regulates HLA-I surface expression in calnexin-expressing but not in calnexin-deficient cells. Virol J 2007, 30:116.
19. Smits H.L., van Gemen B., Schukkink R., van der Velden J., Tjong-A-Hung S.P., Jebbink M.F., et al. Application of the NASBA nucleic acid amplification method for the detection of human papillomavirus type 16 E6-E7 transcripts. J Virol Methods 1995, 54:75-81.
20. Oelze I., Kartenbeck J., Crusius K., Alonso A. Human Papillomavirus type 16 E5 protein affects cell-cell communication in an epithelial cell line. J Virol 1995, 69:4489-4494.
21. Yee C., Krishnan-Hewlett I., Baker C.C., Schlegel R., Howley P.M. Presence and expression of Human Papillomavirus sequences in human cervical carcinoma cell lines. Am J Pathol 1985, 119:361-366.
22. Baker C.C., Phelps W.C., Lindgren V., Braun M.J., Gonda M.A., Howley P.M. Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines. J Virol 1987, 61:962-971.
23. Canadas M.P., Darwich L., Sirera G., Cirigliano V., Bofill M., Clotet M., et al. New molecular method for the detection of human papillomavirus type 16 integration. Clin Microbiol Infect 2010, 16:836-842.
24. Chang J.L., Tsao Y.P., Liu D.W., Huang S.J., Lee W.H., Chen S.L. The expression of HPV-16 E5 protein in squamous neoplastic changes in the uterine cervix. J Biomed Sci 2001, 8:206-213.
25. Molden T., Kraus I., Skomedal H., Nordstrøm T., Karlsen F. PreTect HPV-Proofer: real-time detection and typing of E6/E7 mRNA from carcinogenic human papillomaviruses. J Virol Methods 2007, 142:204-212.
26. Crucius K., Auvinen E., Steuer B., Gaissert H., Alonso A. The human papillomavirus type 16 E5-protein modulates ligand-dependent activation of the EGF receptor family in human epithelial cell line HaCaT. Exp Cell Res 1998, 241:76-83.
27. Kabsch K., Mossadegh N., Kohl A., Komposch G., Schenkel J., Alonso A., et al. The HPV-16 E5 protein inhibits TRAIL- and FasL-mediated apoptosis in human keratinocyte raft cultures. Intervirology 2004, 47:48-56.
28. Zhang B., Spandau D.F., Roman A. E5 protein of human papillomavirus type 16 protects human foreskin keratinocytes from UV B-irradiationinduced apoptosis. J Virol 2002, 76:220-231.
29. Kabsch K., Alonso A. The human papillomavirus type 16 E5 protein impairs TRAIL- and FasL-mediated apoptosis in HaCaT cells by different mechanisms. J Virol 2002, 76:12162-12172.
30. Zhang B., Li P., Wang E., Brahmi Z., Dunn K.W., Blum J.S., et al. The E5 protein of human papillomavirus type 16 perturbs MHC class II antigen maturation in human foreskin keratinocytes treated with interferon-γ. Virology 2003, 310:100-108.
31. Ashrafi G.H., Tsirimonaki E., Marchetti B., O'Brien P.M., Sibbet G.J., Andrew L., et al. Down-regulation of MHC class I by bovine papillomavirus E5 oncoproteins. Oncogene 2002, 21:248-259.
32. Campo M.S., Graham S.V., Cortese M.S., Ashrafi G.H., Araibi E.H., Dornan E.S., et al. HPV-16 E5 down-regulates expression of surface HLA class I and reduces recognition by CD8T cells. Virology 2010, 407:137-142.
33. Schmitt M., Pawlita M. The HPV transcriptome in HPV16 positive cell lines. Mol Cell Probes 2011, 25:108-113.
34. Sherman L., Alloul N., Golan I., Durst M., Baram A. Expression and splicing patterns of human papillomavirus type-16 mRNAs in pre-cancerous lesions and carcinomas of the cervix, in human keratinocytes immortalized by HPV 16, and in cell lines established from cervical cancers. Int J Cancer 1992, 50:356-364.